CoChat

MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound Healing

Open access

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Recent studies suggest that microRNAs play important roles in dermal wound healing and microRNA deregulation has been linked with impaired wound repair. Here, using a mouse experimental wound healing model, we identified a panel of 63 differentially expressed microRNAs during dermal wound healing, including members of miR-99 family (miR-99a, miR-99b, miR-100). We further demonstrated that miR-99 family members regulate cell proliferation, cell migration, and AKT/mTOR signaling. Combined experimental and bioinformatics analyses revealed that miR-99 family members regulate AKT/mTOR signaling by targeting multiple genes, including known target genes (e.g., IGF1R, mTOR) and a new target (AKT1). The effects of miR-99 family members on the expression of IGF1R, mTOR and AKT1 were validated at both the mRNA and protein levels. Two adjacent miR-99 family targeting sites were identified in the 3'-UTR of the AKT1 mRNA. The direct interaction of miR-100 with these targeting sites was confirmed using luciferase reporter assays. The microRNA-100-directed recruitment of AKT1 mRNA to the RNAi-induced silencing complex (RISC) was confirmed by a ribonucleoprotein-IP assay. In summary, we identified a panel of differentially expressed microRNAs which may play important roles in wound healing. We provide evidence that miR-99 family members contribute to wound healing by regulating the AKT/mTOR signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0064434

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Differential expression of microRNA during dermal wound healing. A) MicroRNA microarray profiling analysis was performed on skin biopsies from unwounded mice, and from mice 1 day or 5 days post-wounding (3 mice per groups) as described in Material and Methods section. The levels of 63 microRNAs were changed (p<0.05). Hierarchical clustering analysis was performed based on the differentially expressed microRNAs. A 9-microRNA cluster (mmu-miR-152, mmu-miR-365, mmu-let-7d*, mmu-miR-125a-5p, mmu-miR-181d, mmu-miR-99a, mmu-miR-100, mmu-miR-30c, mmu-miR-125b-5p, which exhibited statistical significant down-regulation on day 1 and returned to basal level on day 5) was named as cluster X (marked by solid bar on the right). B) Principle Component (PC) analysis was performed based on the differentially expressed microRNAs. The first 2 PCs were plotted. Blue: unwounded skin (day 0), Red: 1 day post-wounding, Green: 5 days post-wounding. C) The differential expression of miR-99a, miR99b and miR-100 were confirmed by quantitative RT-PCR in additional mice at 0, 1 and 5 days post-wounding (6 mice per groups). *: p<0.05.
Figure 1 Differential expression of microRNA during dermal wound healing. A) MicroRNA microarray profiling analysis was performed on skin biopsies from unwounded mice, and from mice 1 day or 5 days post-wounding (3 mice per groups) as described in Material and Methods section. The levels of 63 microRNAs were changed (p<0.05). Hierarchical clustering analysis was performed based on the differentially expressed microRNAs. A 9-microRNA cluster (mmu-miR-152, mmu-miR-365, mmu-let-7d*, mmu-miR-125a-5p, mmu-miR-181d, mmu-miR-99a, mmu-miR-100, mmu-miR-30c, mmu-miR-125b-5p, which exhibited statistical significant down-regulation on day 1 and returned to basal level on day 5) was named as cluster X (marked by solid bar on the right). B) Principle Component (PC) analysis was performed based on the differentially expressed microRNAs. The first 2 PCs were plotted. Blue: unwounded skin (day 0), Red: 1 day post-wounding, Green: 5 days post-wounding. C) The differential expression of miR-99a, miR99b and miR-100 were confirmed by quantitative RT-PCR in additional mice at 0, 1 and 5 days post-wounding (6 mice per groups). *: p<0.05.CC BY · PubMed Central
Figure 2 The effect of the miR-99 family on cell proliferation and cell migration in skin keratinocytes. HaCaT cells were transfected with mimics for miR-99a, miR-99b, miR-100 or negative control mimic, or treated with PI3 Kinase Inhibitor LY294002 (LY), mTOR Inhibitor Rapamycin (Rapa) or vehicle alone (DMSO). Cell proliferation was measured by MTT assay (A) and CyQUANT assay (B). Cell migration was measured by scratch assay (C) and trans-well assay (D). Apoptosis was measured by flow cytometry (E). The experiments were performed in quadruplicates. *: p<0.05.
Figure 2 The effect of the miR-99 family on cell proliferation and cell migration in skin keratinocytes. HaCaT cells were transfected with mimics for miR-99a, miR-99b, miR-100 or negative control mimic, or treated with PI3 Kinase Inhibitor LY294002 (LY), mTOR Inhibitor Rapamycin (Rapa) or vehicle alone (DMSO). Cell proliferation was measured by MTT assay (A) and CyQUANT assay (B). Cell migration was measured by scratch assay (C) and trans-well assay (D). Apoptosis was measured by flow cytometry (E). The experiments were performed in quadruplicates. *: p<0.05.CC BY · PubMed Central
Figure 3 The effect of miR-100 on the phosphorylation of p70S6K and 4E-BP1. HaCaT cells were transfected with either negative control mimic (A) or miR-100 mimic (B), and then stimulated with IGF1 or serum. Western blot analysis was performed to assess the levels of total p70S6K protein, phosphorylated p70S6K, total 4E-BP1 protein, and phosphorylated 4E-BP1.
Figure 3 The effect of miR-100 on the phosphorylation of p70S6K and 4E-BP1. HaCaT cells were transfected with either negative control mimic (A) or miR-100 mimic (B), and then stimulated with IGF1 or serum. Western blot analysis was performed to assess the levels of total p70S6K protein, phosphorylated p70S6K, total 4E-BP1 protein, and phosphorylated 4E-BP1.CC BY · PubMed Central
Figure 4 The effect of the miR-99 family on the expression of mTOR, IGF1R and AKT. HaCaT cells were transfected with mimics for miR-99a, miR-99b, miR-100 or negative control mimic. Western blot analysis was performed to measure the protein levels of mTOR, IGF1R, AKT1, AKT2 and AKT3 (A). Quantitative RT-PCR assays were performed to measure the mRNA levels of mTOR (B), IGF1R (C), and AKT1 (D). *: p<0.05.
Figure 4 The effect of the miR-99 family on the expression of mTOR, IGF1R and AKT. HaCaT cells were transfected with mimics for miR-99a, miR-99b, miR-100 or negative control mimic. Western blot analysis was performed to measure the protein levels of mTOR, IGF1R, AKT1, AKT2 and AKT3 (A). Quantitative RT-PCR assays were performed to measure the mRNA levels of mTOR (B), IGF1R (C), and AKT1 (D). *: p<0.05.CC BY · PubMed Central
Figure 5 MicroRNA-100 directly interacts with AKT1 mRNA. A) Two adjacent targeting sites for miR-99a/b/100 were identified in AKT1 3′-UTRs (nt 2175 to nt 2235, NM_005163). B) Dual luciferase reporter assays were performed to test the interactions of miR-100 and the targeting sequences in the AKT1 mRNA using constructs containing the predicted targeting sequences and the corresponding mutants cloned into the 3′-UTR of the reporter gene. C) RIP-IP assays were performed to co-IP the Ago2 complexes from cells transfected with either miR-100 mimic or negative control mimic. qRT-PCR assays were performed on RNA samples isolated from the Ago2 co-IP fractions to measure the relative enrichment of the AKT1 mRNA. Data represent at least 3 independent experiments with similar results. *: p<0.05.
Figure 5 MicroRNA-100 directly interacts with AKT1 mRNA. A) Two adjacent targeting sites for miR-99a/b/100 were identified in AKT1 3′-UTRs (nt 2175 to nt 2235, NM_005163). B) Dual luciferase reporter assays were performed to test the interactions of miR-100 and the targeting sequences in the AKT1 mRNA using constructs containing the predicted targeting sequences and the corresponding mutants cloned into the 3′-UTR of the reporter gene. C) RIP-IP assays were performed to co-IP the Ago2 complexes from cells transfected with either miR-100 mimic or negative control mimic. qRT-PCR assays were performed on RNA samples isolated from the Ago2 co-IP fractions to measure the relative enrichment of the AKT1 mRNA. Data represent at least 3 independent experiments with similar results. *: p<0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Jiang L, Liu X, Chen Z, Jin Y, Heidbreder CE, et al (2010) MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 432: 199– 205. 20819078 PMC3130335 · DOI · Paper page

Cited by

See all 172

Metadata

Authors
Jin, Y., Tymen, S. D., Chen, D., Fang, Z. J., Zhao, Y., Dragas, D., Dai, Y., Marucha, P. T., & Zhou, X.
Affiliations
  • University of Illinois Chicago (US)
  • Sun Yat-sen University (CN)
Corresponding author
  • Marucha, Phillip T.
  • Zhou, Xiaofeng
Venue
PLoS ONE
Published
2013-05-28
Volume
8
Issue
5
Pages
e64434
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1980231360
Cited by
172
References
46
Citations by year
2026: 2 · 2025: 5 · 2024: 11 · 2023: 9 · 2022: 9 · 2021: 11 · 2020: 22 · 2019: 10 · 2018: 16 · 2017: 27 · 2016: 17 · 2015: 16 · 2014: 14 · 2013: 3
FWCI
17.84
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Institutes of Health (NIH T32, 5p20gm078426-04, CA139596)
  • University of Illinois at Urbana-Champaign (UL1RR029879)
  • University of Illinois at Chicago (UL1RR029879)
  • National Cancer Institute (CA139596, R01CA139596)
  • National Institute of General Medical Sciences (GM078426, P20‐GM078426)
  • National Institute of Dental and Craniofacial Research (T32DE018381, R01DE017686, R25DE022675, DE017686)
  • National Center for Research Resources (UL1RR029879)
Topics
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
miR-99a, miR-99b, miR-100, skin wound healing, Akt/mTOR signaling, AKT1, IGF-1 receptor, mTOR, miRNA target genes, cell proliferation, cell migration, RNA-induced silencing complex
MeSH terms
Animals, Base Sequence, Carrier Proteins, Cell Movement, Female, Humans, Molecular Sequence Data, Phosphoproteins, Phosphorylation, RNA, Messenger, Wound Healing, Signal Transduction, Keratinocytes, Receptor, IGF Type 1, Cell Cycle Proteins, Dermis, Gene Expression Profiling, MicroRNAs, Ribosomal Protein S6 Kinases, 70-kDa, Eukaryotic Initiation Factors, Adaptor Proteins, Signal Transducing, Cell Proliferation, Proto-Oncogene Proteins c-akt, Mice, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.